|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/20 | |||
| A61K 31/437 | |||
| A61K 47/32 | |||
| A61K 47/38 | |||
| A61P 7/02 |
| (11) | Number of the document | 2854759 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13723415.9 |
| Date of filing the European patent application | 2013-05-16 | |
| (97) | Date of publication of the European application | 2015-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/001461 |
| Date | 2013-05-16 |
| (87) | Number | WO 2013/174498 |
| Date | 2013-11-28 |
| (30) | Number | Date | Country code |
| 12004041 | 2012-05-24 | EP | |
| 201213479549 | 2012-05-24 | US |
| (72) |
MEERGANS, Dominique, DE
LEUTNER, Dirk, DE
|
| (73) |
ratiopharm GmbH,
Graf-Arco-Strasse 3, 89079 Ulm,
DE
|
| (54) | DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER |
| DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER |